Short answer
Arcturus Therapeutics Holdings Inc. (ARCT) filed an 8-K current report with the SEC on June 5, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). 2026 annual meeting achieved quorum with 21,435,189 shares represented out of 28,423,069 eligible shares.
Arcturus Therapeutics Holdings Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- 2026 annual meeting achieved quorum with 21,435,189 shares represented out of 28,423,069 eligible shares
- All eight listed director nominees elected through the 2027 annual meeting, with 15,521,066–15,660,970 votes for each
- Say-on-pay approved, with 15,254,240 votes for versus 327,647 against and 176,375 abstentions
- Deloitte & Touche appointment ratified for fiscal 2026, with 21,378,017 votes for and 46,823 against
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Arcturus Therapeutics Holdings Inc. 8-K filings
Get the next ARCT 8-K as it lands
Follow ARCT for push alerts, or ask the research agent what this filing means.